Nothing Special   »   [go: up one dir, main page]

RS50288B - Amycomycin, postupak za njegovu proizvodnju i njegova upotreba kao farmaceutika - Google Patents

Amycomycin, postupak za njegovu proizvodnju i njegova upotreba kao farmaceutika

Info

Publication number
RS50288B
RS50288B YUP-131/02A YUP13102A RS50288B RS 50288 B RS50288 B RS 50288B YU P13102 A YUP13102 A YU P13102A RS 50288 B RS50288 B RS 50288B
Authority
RS
Serbia
Prior art keywords
amycomycin
pharmaceutical
production
stereoisomeric
ethers
Prior art date
Application number
YUP-131/02A
Other languages
English (en)
Inventor
Cordula Hopmann
Michael Kurz
Heinrich Decker
Dominique Le Beller
Jozsef Aszodi
Original Assignee
Sanofi-Aventis Deutschland Gmbh.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Aventis Deutschland Gmbh., filed Critical Sanofi-Aventis Deutschland Gmbh.,
Publication of YU13102A publication Critical patent/YU13102A/sh
Publication of RS50288B publication Critical patent/RS50288B/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/44—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Jedinjenje formule: i njegove farmaceutski prihvatljive soli, estri i etri u svim svojim stereoizomernim i tautomernim oblicima. Prijava sadrži još 5 nezavisnih i 1 zavisan patentni zahtev.
YUP-131/02A 1999-12-08 2000-11-25 Amycomycin, postupak za njegovu proizvodnju i njegova upotreba kao farmaceutika RS50288B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99124456A EP1106604A1 (en) 1999-12-08 1999-12-08 Amycomycin, a process for its production and its use as a pharmaceutical

Publications (2)

Publication Number Publication Date
YU13102A YU13102A (sh) 2005-06-10
RS50288B true RS50288B (sr) 2009-09-08

Family

ID=8239554

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-131/02A RS50288B (sr) 1999-12-08 2000-11-25 Amycomycin, postupak za njegovu proizvodnju i njegova upotreba kao farmaceutika

Country Status (28)

Country Link
US (1) US6642391B2 (sr)
EP (2) EP1106604A1 (sr)
JP (1) JP4750993B2 (sr)
KR (1) KR100728514B1 (sr)
CN (1) CN1217929C (sr)
AT (1) ATE298744T1 (sr)
AU (1) AU781398B2 (sr)
BR (1) BR0016223A (sr)
CA (1) CA2393518C (sr)
CZ (1) CZ294370B6 (sr)
DE (1) DE60021109T2 (sr)
DK (1) DK1237866T3 (sr)
EE (1) EE05219B1 (sr)
ES (1) ES2243332T3 (sr)
HK (1) HK1048998A1 (sr)
HR (1) HRP20020497B1 (sr)
HU (1) HU225194B1 (sr)
IL (2) IL149904A0 (sr)
ME (1) MEP28508A (sr)
NO (1) NO322565B1 (sr)
PL (1) PL201809B1 (sr)
PT (1) PT1237866E (sr)
RS (1) RS50288B (sr)
RU (1) RU2261916C2 (sr)
SI (1) SI1237866T1 (sr)
SK (1) SK286776B6 (sr)
WO (1) WO2001042210A1 (sr)
ZA (1) ZA200204420B (sr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102417919B (zh) * 2011-09-02 2017-05-24 山东鲁抗医药股份有限公司 一种发酵法生产高纯度替考拉宁的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8700513D0 (en) * 1987-01-09 1987-02-11 Pfizer Ltd Antibiotics produced by fermentation
CA2016382A1 (en) * 1989-05-12 1990-11-12 Marvin M. Hoehn A59770 antibiotics
JPH05163289A (ja) * 1991-08-27 1993-06-29 Microbial Chem Res Found 新規な免疫抑制物質、ｍｉ７１０−５１ｆ６物質およびその製造法
JPH05286990A (ja) * 1992-04-08 1993-11-02 Meiji Seika Kaisha Ltd 新規マクロライド抗生物質および微生物変換を利用したマクロライド抗生物質の製造法
JP3107455B2 (ja) * 1992-05-08 2000-11-06 財団法人微生物化学研究会 新規抗生物質ｍｉ４８１−４２ｆ４−ａ及びその製造方法
JPH05317068A (ja) * 1992-05-14 1993-12-03 Kaiyo Bio Technol Kenkyusho:Kk 抗生物質マグネシジンの一成分の選択的製造法
JPH0733736A (ja) * 1993-07-26 1995-02-03 Microbial Chem Res Found 新規抗生物質アジセマイシンｂおよびその製造方法
JPH09157266A (ja) * 1995-12-04 1997-06-17 Microbial Chem Res Found 新規抗生物質エポキシキノマイシンａおよびｂとその製造法
EP0816539A1 (de) 1996-07-05 1998-01-07 Maschinenfabrik Rieter Ag Verfahren und Vorrichtung zur Produktionssteuerung an einer Karde
JPH1045738A (ja) * 1996-07-29 1998-02-17 Microbial Chem Res Found 抗生物質エポキシキノマイシンｃおよびｄとその製造法ならびに抗リウマチ剤
JPH10114777A (ja) * 1996-10-09 1998-05-06 Microbial Chem Res Found 抗生物質スピロキシマイシンとその製造法

Also Published As

Publication number Publication date
CA2393518C (en) 2009-01-20
HRP20020497A2 (en) 2004-08-31
DK1237866T3 (da) 2005-10-10
PT1237866E (pt) 2005-10-31
ATE298744T1 (de) 2005-07-15
WO2001042210A1 (en) 2001-06-14
EE05219B1 (et) 2009-10-15
YU13102A (sh) 2005-06-10
SK286776B6 (sk) 2009-05-07
RU2261916C2 (ru) 2005-10-10
CZ20021891A3 (cs) 2002-08-14
NO20022654L (no) 2002-06-05
HUP0203593A3 (en) 2003-12-29
HRP20020497B1 (en) 2006-04-30
EP1237866B1 (en) 2005-06-29
NO20022654D0 (no) 2002-06-05
PL201809B1 (pl) 2009-05-29
HK1048998A1 (en) 2003-04-25
HUP0203593A2 (hu) 2003-02-28
JP2003516389A (ja) 2003-05-13
US6642391B2 (en) 2003-11-04
EP1237866A1 (en) 2002-09-11
IL149904A0 (en) 2002-11-10
CZ294370B6 (cs) 2004-12-15
PL355627A1 (en) 2004-05-04
US20010018450A1 (en) 2001-08-30
EP1106604A1 (en) 2001-06-13
KR100728514B1 (ko) 2007-06-15
ZA200204420B (en) 2003-09-03
DE60021109T2 (de) 2006-05-04
RU2002118116A (ru) 2004-02-27
NO322565B1 (no) 2006-10-23
HU225194B1 (en) 2006-08-28
KR20020063205A (ko) 2002-08-01
JP4750993B2 (ja) 2011-08-17
SI1237866T1 (en) 2005-10-31
CN1217929C (zh) 2005-09-07
ME00182B (me) 2010-10-10
BR0016223A (pt) 2002-09-10
IL149904A (en) 2007-10-31
SK7872002A3 (en) 2002-11-06
CA2393518A1 (en) 2001-06-14
AU2001901A (en) 2001-06-18
AU781398B2 (en) 2005-05-19
DE60021109D1 (de) 2005-08-04
ES2243332T3 (es) 2005-12-01
MEP28508A (en) 2010-10-10
EE200200280A (et) 2003-06-16
CN1377341A (zh) 2002-10-30

Similar Documents

Publication Publication Date Title
YU69902A (sh) Novi derivati piperazina
DE69831868D1 (en) Antithrombosemittel
SE9504661D0 (sv) New compounds
DE69830504D1 (de) Antithrombotische mitteln
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
BG103413A (en) Derivatives of sulphinic acid, their production and application
ATE349432T1 (de) 2-anilino-pyrimidin-derivate als cyclin-abhängige kinase hemmer
CA2379026A1 (en) Substituted thiene-3-yl-sulphonylamino(thio)carbonyl-triazolin(thi)ones
IS6614A (is) Ný tríasólpýrimídínefnasambönd
MX9700885A (es) Nuevas heteroariloxazolidinonas.
MXPA03011954A (es) Nuevos derivados de acido sulfonico.
YU30603A (sh) Derivati premošćenog piperazina
DE60114640D1 (en) Antithrombosemittel
EP1900741A8 (en) New process for the production of oxabispidines
BR0114380A (pt) Derivados-1-aminobutan-3-ol-substituìdos
MY133169A (en) Substituted heterocyclic benzocycloalkenes and the use thereof as substances having an analgesic effect
SE9504662D0 (sv) New compounds
HRP20010885B1 (en) Ethanesulfonyl-piperidine derivatives
IT1273790B (it) Derivati eterociclici diazotati aventi attivita' aii antagonista
RS50288B (sr) Amycomycin, postupak za njegovu proizvodnju i njegova upotreba kao farmaceutika
AP2002002595A0 (en) Heterocyclic amide derivatives.
SE9902742D0 (sv) New pharmaceutical formultion
MXPA04001852A (es) Uso de sistemas indan-1-ol c2-sustituidas para la produccion de medicamentos para la profilaxis o tratamiento de obesidad.
MXPA04001856A (es) Indan-1-oles c2-sustituidos y sus derivados, metodo para su produccion y su uso como medicamentos.
MXPA03003466A (es) Derivados de piranosido.